Amdocs (DOX)
(Delayed Data from NSDQ)
$87.29 USD
+1.03 (1.19%)
Updated Sep 19, 2024 04:00 PM ET
4-Sell of 5 4
B Value D Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for Amdocs Limited falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 542.96 | 549.50 | 688.37 | 497.84 | 479.45 |
Depreciation/Amortization & Depletion | 196.28 | 225.10 | 209.38 | 198.55 | 205.77 |
Net Change from Assets/Liabilities | 51.14 | -79.12 | 249.10 | -110.93 | -54.18 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 32.25 | 61.24 | -221.04 | 72.67 | 25.34 |
Net Cash From Operating Activities | 822.63 | 756.72 | 925.81 | 658.14 | 656.38 |
Property & Equipment | -124.36 | -227.22 | -210.44 | -205.51 | -128.09 |
Acquisition/ Disposition of Subsidiaries | -121.82 | -14.43 | 146.29 | -249.36 | -60.57 |
Investments | 25.98 | -12.33 | -258.77 | -0.75 | 101.29 |
Other Investing Activities | -4.30 | -8.53 | -6.08 | -6.10 | 0.62 |
Net Cash from Investing Activities | -224.50 | -262.50 | -329.00 | -461.73 | -86.76 |
Uses of Funds
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -440.84 | -425.55 | -590.94 | -263.06 | -356.57 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -100.00 | 743.92 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -199.46 | -186.07 | -177.47 | -164.06 | -147.62 |
Other Financing Activities | -11.13 | -18.28 | -2.52 | -1.65 | -12.58 |
Net Cash from Financing Activities | -651.43 | -629.91 | -870.93 | 315.15 | -516.77 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -53.30 | -135.69 | -274.12 | 511.56 | 52.85 |
Cash at Beginning of Period | 573.38 | 709.06 | 983.19 | 471.63 | 418.78 |
Cash at End of Period | 520.08 | 573.38 | 709.06 | 983.19 | 471.63 |
Diluted Net EPS | 4.49 | 4.44 | 5.32 | 3.71 | 3.47 |
Fiscal Year End for Amdocs Limited falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 409.15 | 268.15 | 148.72 | 542.96 | 440.30 |
Depreciation/Amortization & Depletion | 144.18 | 98.15 | 46.01 | 196.28 | 148.84 |
Net Change from Assets/Liabilities | -118.22 | -108.87 | -32.29 | 51.14 | -60.07 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 71.40 | 57.62 | 19.95 | 32.25 | 21.18 |
Net Cash From Operating Activities | 506.51 | 315.04 | 182.39 | 822.63 | 550.26 |
Property & Equipment | -79.68 | -63.35 | -43.74 | -124.36 | -97.81 |
Acquisition/ Disposition of Subsidiaries | -86.82 | -87.13 | -77.33 | -121.82 | -84.43 |
Investments | 40.46 | 22.08 | 8.53 | 25.98 | 15.55 |
Other Investing Activities | 4.18 | -0.39 | 0.93 | -4.30 | -2.44 |
Net Cash from Investing Activities | -121.87 | -128.79 | -111.61 | -224.50 | -169.12 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -424.20 | -257.88 | -154.10 | -440.84 | -288.52 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -157.26 | -101.74 | -51.05 | -199.46 | -147.68 |
Other Financing Activities | -5.27 | -3.81 | -2.82 | -11.13 | -0.66 |
Net Cash from Financing Activities | -586.73 | -363.42 | -207.97 | -651.43 | -436.86 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -202.09 | -177.17 | -137.20 | -53.30 | -55.72 |
Cash at Beginning of Period | 520.08 | 520.08 | 520.08 | 573.38 | 573.38 |
Cash at End of Period | 317.99 | 342.92 | 382.89 | 520.08 | 517.66 |
Diluted Net EPS | 1.21 | 1.01 | 1.26 | 0.87 | 1.32 |